Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities

CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities

US Patent 9803021 · Granted Oct 31, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for 2025
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFN2024
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFN2023
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFN2021
CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activitie2021
Anti-CSPG4 fusions with interferon for the treatment of malignancy2020
Targeted interferons demonstrate potent apoptotic and anti-tumor activities2019
Anti-CSPG4 fusions with interferon for the treatment of malignancy2018
Antibody-endostatin fusion protein and its variants2017
Targeted interferons demonstrating potent apoptotic and anti-tumor activities2017
Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumo2015
Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumo2013